- Q1 2024 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 08, 2024$9.61 (+0.63%)Earnings
- Q4 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptFeb 28, 2024$5.35 (-3.78%)Earnings
- Mind Medicine (MindMed) Inc to Host Conference Call TranscriptDec 14, 2023
- Q3 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 02, 2023$2.7 (+8.43%)Earnings
- Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Q2 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 03, 2023$4.71 (+2.61%)Earnings
- Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 04, 2023$3.62 (-1.90%)Earnings
- Mind Medicine (MindMed) Inc at ROTH Conference TranscriptMar 13, 2023
- Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 09, 2023$3.18 (-4.79%)Earnings
- Mind Medicine (MindMed) Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Mind Medicine (MindMed) Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 10, 2022$2.6 (+7.88%)Earnings
- Q2 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 11, 2022$9.75 (-0.21%)Earnings
- Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- Q1 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 16, 2022$12.01 (+2.64%)Earnings
- Q4 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 28, 2022$17.4 (-1.69%)Earnings
- Q2 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 16, 2021Earnings
Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Okay. All right. Thanks for joining this afternoon, Oppenheimer Healthcare Conference. I know it's been a very busy time for a lot of people, so I appreciate the time.
Next presenter here we have Rob Barrow, who is CEO of Mind Med. Just full disclosure, we cover Mind Med at Oppenheimer. I'm Frank Brisebois, one of the senior biotech analysts at the firm.
And with that, Rob, thanks for joining, I think what would be helpful in terms of format, we'll just do a fireside chat. I think it would be most helpful is just maybe to those that aren't familiar, just an overview of the company.
()-&
Yeah. Thanks so much, Frank. Thanks for having us here. So to give high-level overview. We're a company headquartered in New York. It's developing the psychedelic drug class. And we've taken a particularly unique approach and the opportunity of developing these molecules. And it's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)